Bifidobacterium (animalis) lactis – CNCM I-2494

Tabella dei contenuti

Clinical indications

constipation, ibs

Area of use


Gastroenterology | Constipation

Characteristics

DAILY DOSAGE IN CLINICAL STUDY

10 billion CFU serving; 1-3 serving/die

 

FUNCTIONALITY
Constipation

Scientific support

Human clinical trial
Yang, Y.X., M. He, G. Hu, J. Wei, P. Pages, X.H. Yang, and S. Bourdu-Naturel. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women. World J Gastroenterol 14.40 (2008): 6237-6243.


Gastroenterology | IBS -Irritable bowel syndrome

Characteristics

DAILY DOSAGE IN CLINICAL STUDY
10 billion CFU serving; 1-3 serving/die

FUNCTIONALITY
Irritable bowel syndrome

Scientific support

Human clinical trial

Agrawal, A., Lesley A. Houghton, J. Morris, B. Reilly, D. Guyonnet, N. Goupil Feuillerat, A. Schlumberger, S. Jakob, and P. J. Whorwell. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN‐173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Alimentary pharmacology & therapeutics 29.1 (2009): 104-114.

 

Guyonnet, D., O. Chassany, P. Ducrotte, C. Picard, M. Mouret, C‐H. Mercier, and C. Matuchansky. Effect of a fermented milk containing Bifidobacterium animalis DN‐173 010 on the health‐related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double‐blind, controlled trial. Alimentary pharmacology & therapeutics 26.3 (2007): 475-486.

Oppure effettua il login